Odyssean »

Enova Intl shares owned by Odyssean

Quarter-by-quarter ownership of Enova Intl (ENVA) shares owned by Odyssean from 13F filings

Historical chart of Odyssean investment in Enova Intl

Tip: Access up to 7 years of quarterly data

All positions including Enova Intl held by Odyssean consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Enova Intl by Odyssean

Quarter filed Position value Share count Share price at filing
2026-06-30 $524k 2.2k 240.73

More positions owned by Odyssean

Ultragenyx Pharmaceutical (RARE)
Kymera Therapeutics (KYMR)
Ideaya Biosciences (IDYA)
Vaxcyte (PCVX)
Affirm Hldgs Com Cl A (AFRM)
Celldex Therapeutics Com New (CLDX)
Loar Holdings Com Shs (LOAR)
Mirum Pharmaceuticals (MIRM)
Doordash Cl A (DASH)
Krystal Biotech (KRYS)
Viking Holdings Ord Shs (VIK)
Medpace Hldgs (MEDP)
Toast Cl A (TOST)
American Healthcare Reit Com Shs (AHR)
Nicolet Bankshares (NIC)

View all positions for Odyssean

Top funds holding Enova Intl

BlackRock
Vanguard Capital Management
State Street Corporation
Invesco
Dimensional Fund Advisors
Vanguard Portfolio Management
Renaissance Technologies
Geode Capital Management
FMR
Franklin Resources
SG Capital Management
American Century Companies
T. Rowe Price Associates
Charles Schwab Investment Management
Empyrean Capital Partners

View all funds holding Enova Intl